粘质沙雷氏菌DNA促旋酶gyrA基因的克隆、核苷酸序列分析及喹诺酮耐药临床分离株gyrA基因突变特征
Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates.
作者信息
Kim J H, Cho E H, Kim K S, Kim H Y, Kim Y M
机构信息
Department of Pharmacology and Molecular Biology, C&C Research Laboratories, Kyunggi-do, Korea.
出版信息
Antimicrob Agents Chemother. 1998 Jan;42(1):190-3. doi: 10.1128/AAC.42.1.190.
Abstract
The sequence of the DNA gyrase gyrA gene of Serratia marcescens ATCC 14756 was determined. An open reading frame of 2,640 nucleotides coding for a polypeptide with a calculated molecular mass of 97,460 was found, and its sequence complemented the sequence of an Escherichia coli gyrA temperature-sensitive mutation. Analysis of the PCR products of the quinolone resistance-determining regions of gyrA genes from six quinolone-resistant clinical isolates revealed a single amino acid substitution, Ser-83 to Arg or Asp-87 to Tyr, in all six mutants, suggesting that a mutational alteration in gyrA is a common mechanism of quinolone resistance in S. marcescens.
摘要
测定了粘质沙雷氏菌ATCC 14756的DNA促旋酶gyrA基因序列。发现一个2640个核苷酸的开放阅读框，编码一个计算分子量为97460的多肽，其序列补充了大肠杆菌gyrA温度敏感突变的序列。对来自六个喹诺酮耐药临床分离株的gyrA基因喹诺酮耐药决定区的PCR产物分析显示，所有六个突变体中均有一个氨基酸取代，即Ser-83突变为Arg或Asp-87突变为Tyr，这表明gyrA的突变改变是粘质沙雷氏菌喹诺酮耐药的常见机制。
相似文献
1
Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates.
Antimicrob Agents Chemother. 1998 Jan;42(1):190-3. doi: 10.1128/AAC.42.1.190.
2
Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates.
Antimicrob Agents Chemother. 1994 Sep;38(9):1944-52. doi: 10.1128/AAC.38.9.1944.
3
Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.
Antimicrob Agents Chemother. 1991 May;35(5):898-902. doi: 10.1128/AAC.35.5.898.
4
Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
Mol Microbiol. 1994 Aug;13(4):641-53. doi: 10.1111/j.1365-2958.1994.tb00458.x.
5
Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations.
Antimicrob Agents Chemother. 1993 Mar;37(3):457-63. doi: 10.1128/AAC.37.3.457.
6
Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.
Antimicrob Agents Chemother. 1994 Sep;38(9):2014-23. doi: 10.1128/AAC.38.9.2014.
7
Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
Am J Med. 1989 Nov 30;87(5A):2S-8S. doi: 10.1016/0002-9343(89)90010-7.
8
Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
J Antimicrob Chemother. 1997 Oct;40(4):543-9. doi: 10.1093/jac/40.4.543.
9
Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR.
Antimicrob Agents Chemother. 1994 Oct;38(10):2488-91. doi: 10.1128/AAC.38.10.2488.
10
Cloning and nucleotide sequence of the gyrA gene from Campylobacter fetus subsp. fetus ATCC 27374 and characterization of ciprofloxacin-resistant laboratory and clinical isolates.
Antimicrob Agents Chemother. 1997 Mar;41(3):665-71. doi: 10.1128/AAC.41.3.665.
引用本文的文献
1
Comparative Genomic Analysis of Multi-Drug Resistant Sequence Type 235 Isolated from Sudan.
Microorganisms. 2023 May 29;11(6):1432. doi: 10.3390/microorganisms11061432.
2
Healthcare-associated infections caused by chlorhexidine-tolerant Serratia marcescens carrying a promiscuous IncHI2 multi-drug resistance plasmid in a veterinary hospital.
PLoS One. 2022 Mar 17;17(3):e0264848. doi: 10.1371/journal.pone.0264848. eCollection 2022.
3
Differential distribution of plasmid-mediated quinolone resistance genes in clinical enterobacteria with unusual phenotypes of quinolone susceptibility from Argentina.
Antimicrob Agents Chemother. 2013 Jun;57(6):2467-75. doi: 10.1128/AAC.01615-12. Epub 2013 Mar 11.
4
Identification of a Serratia marcescens clinical isolate with multiple quinolone resistance mechanisms from China.
Antimicrob Agents Chemother. 2012 Oct;56(10):5426-7. doi: 10.1128/AAC.00070-12. Epub 2012 Aug 13.
5
Serratia infections: from military experiments to current practice.
Clin Microbiol Rev. 2011 Oct;24(4):755-91. doi: 10.1128/CMR.00017-11.
6
Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility.
Antimicrob Agents Chemother. 2006 Sep;50(9):3179-82. doi: 10.1128/AAC.00218-06.
7
Analysis of the gyrA gene of clinical Yersinia ruckeri isolates with reduced susceptibility to quinolones.
Appl Environ Microbiol. 2004 Jan;70(1):599-602. doi: 10.1128/AEM.70.1.599-602.2004.
8
Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.
Antimicrob Agents Chemother. 2003 Nov;47(11):3567-73. doi: 10.1128/AAC.47.11.3567-3573.2003.
9
Effects of rice seed surface sterilization with hypochlorite on inoculated Burkholderia vietnamiensis.
Appl Environ Microbiol. 2001 Jul;67(7):3046-52. doi: 10.1128/AEM.67.7.3046-3052.2001.
10
Mechanisms of fluoroquinolone resistance: an update 1994-1998.
Drugs. 1999;58 Suppl 2:11-8. doi: 10.2165/00003495-199958002-00003.
本文引用的文献
1
Development of fluoroquinolone resistance in Enterococcus faecalis and role of mutations in the DNA gyrase gyrA gene.
Antimicrob Agents Chemother. 1996 Nov;40(11):2558-61. doi: 10.1128/AAC.40.11.2558.
2
ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype.
Antimicrob Agents Chemother. 1996 Oct;40(10):2252-7. doi: 10.1128/AAC.40.10.2252.
3
Sequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in vitro-selected quinolone-resistant strain of Coxiella burnetii.
Antimicrob Agents Chemother. 1996 Apr;40(4):870-3. doi: 10.1128/AAC.40.4.870.
4
DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Staphylococcus haemolyticus.
Antimicrob Agents Chemother. 1996 Apr;40(4):1065-6. doi: 10.1128/AAC.40.4.1065.
5
Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals.
Antimicrob Agents Chemother. 1996 Apr;40(4):1009-13. doi: 10.1128/AAC.40.4.1009.
6
Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC.
Antimicrob Agents Chemother. 1996 Jul;40(7):1741-4. doi: 10.1128/AAC.40.7.1741.
7
Cloning and nucleotide sequence of the DNA gyrase gyrA gene from the fish pathogen Aeromonas salmonicida.
Antimicrob Agents Chemother. 1996 May;40(5):1126-33. doi: 10.1128/AAC.40.5.1126.
8
Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations.
Antimicrob Agents Chemother. 1993 Mar;37(3):457-63. doi: 10.1128/AAC.37.3.457.
9
Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations.
Antimicrob Agents Chemother. 1994 Apr;38(4):773-80. doi: 10.1128/AAC.38.4.773.
10
Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs.
Antimicrob Agents Chemother. 1994 Oct;38(10):2477-9. doi: 10.1128/AAC.38.10.2477.
Zotero 插件